AMANDA MAZZELLA: Open Payments
NPI 1093474835 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 17 payments from 7 companies in 2025. Trend: 2023 $610 · 2024 $509 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $259 |
| Xeris Pharmaceuticals, Inc. | 5 | $191 |
| Novo Nordisk Inc | 5 | $190 |
| Abbott Laboratories | 3 | $182 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $162 |
| Corcept Therapeutics | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
Products named: CeQur Simplicity, GVOKE HYPOPEN, FREESTYLE LIBRE 3, Ozempic, Kerendia, Korlym, TZIELD, Rybelsus.
Industry payments across FL — which companies pay providers there.
